Share on StockTwits

Oragenics (NASDAQ:OGEN) CEO John N. Bonfiglio purchased 1,000 shares of the stock in a transaction dated Wednesday, August 13th. The stock was purchased at an average price of $1.70 per share, with a total value of $1,700.00. Following the completion of the purchase, the chief executive officer now directly owns 385,255 shares in the company, valued at approximately $654,934. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Shares of Oragenics (NASDAQ:OGEN) opened at 1.78 on Friday. Oragenics has a 52 week low of $1.56 and a 52 week high of $4.65. The stock has a 50-day moving average of $1.88 and a 200-day moving average of $2.47. The company’s market cap is $64.4 million.

Oragenics (NASDAQ:OGEN) last released its earnings data on Thursday, May 22nd. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.04. Analysts expect that Oragenics will post $-0.37 EPS for the current fiscal year.

Oragenics, Inc is focused on the discovery, development and commercialization of a range of technologies associated with oral health, antibiotics and other general health benefits.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.